Last reviewed · How we verify
Mesenchymal Stem Cells Transplantation
At a glance
| Generic name | Mesenchymal Stem Cells Transplantation |
|---|---|
| Sponsor | SBÜ Dr. Sadi Konuk Eğitim ve Araştırma Hastanesi |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
- Anaemia
- Thrombocytopenia
- Cytomegalovirus infection reactivation
- Oedema peripheral
- Neutropenia
- Hypokalaemia
- Platelet count decreased
- Nausea
- Pyrexia
- Vomiting
- fever
- Hypomagnesaemia
Key clinical trials
- Study Comparing Two Methods for the Treatment of Large Chondral and Osteochondral Defects of the Knee (NA)
- Combination of Conditioned Medium and Umbilical Cord-Mesenchymal Stem Cells Therapy for Acute Stroke Infarct (PHASE1, PHASE2)
- Long-term Safety of UC-MSC Transplantation in Patients With Retinitis Pigmentosa
- Role of UC-MSC and CM to Inhibit Vision Loss in Retinitis Pigmentosa Phase I/II (PHASE2, PHASE3)
- Evaluation of Umbilical Cord-Derived Wharton's Jelly Stem Cells for the Treatment of Acute Graft Versus Host Disease (PHASE1)
- PT-MSCs Exosome Injection in the Treatment of Chronic-to-acute Liver Failure (EARLY_PHASE1)
- Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA (PHASE1, PHASE2)
- Amimestrocel Injection for Preventing Severe Oral Mucositis in HSCT Patients (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |